Perspective Therapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Perspective Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $30.63 million for the year ending 2025.

  • Perspective Therapeutics, Inc. showed a decrease of -50.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Perspective Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2011 to 2025), Perspective Therapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,350.1%.
  • Historical annual values: Fiscal year 2025: $30.63 million | Fiscal year 2024: $61.58 million | Fiscal year 2023: $9.24 million | Fiscal year 2022: $20.99 million | Fiscal year 2022: $55.89 million | Fiscal year 2021: $63.83 million | Fiscal year 2020: $2.39 million | Fiscal year 2019: $5.33 million | Fiscal year 2018: $2.60 million | Fiscal year 2017: $5.93 million | Fiscal year 2016: $10.14 million | Fiscal year 2015: $5.23 million | Fiscal year 2014: $7.68 million | Fiscal year 2013: $2.90 million | Fiscal year 2012: $2.67 million | Fiscal year 2011: $2.11 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: